Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-02-09 00:00:00 ET · period of report 2022-02-07 · accession 0001209191-22-008124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-02-09 | 2022-02-07 | KPTI | Kauffman Michael | Dir | S - Sale | $9.86 | -6,707 | 913.4K | -0.7% | -$66.1K |
| 2022-02-09 | 2022-02-07 | KPTI | Kauffman Michael | Dir | S - Sale | $9.86 | -6,764 | 708.1K | -0.9% | -$66.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-07 | S | D | 6,707 | $9.86 | 913,445 | I | — | — | (F4) The sale price of the spouse of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. |
| 2 | Common | Common Stock | 2022-02-07 | S | D | 6,764 | $9.86 | 708,062 | D By Spouse | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. |